CLINICAL_TRIALS
trial_result
· 2019-12-17
Clinical Trial Update: A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors [Phase 1]
Summary
Phase 1 trial assessing talazoparib's impact on cardiac repolarization in patients with advanced solid tumors has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2019-12-17